Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 2
1983 1
1984 5
1985 6
1986 14
1987 5
1988 11
1989 13
1990 11
1991 12
1992 5
1993 10
1994 6
1995 10
1996 11
1997 5
1998 20
1999 16
2000 18
2001 21
2002 35
2003 54
2004 62
2005 86
2006 85
2007 116
2008 104
2009 128
2010 160
2011 243
2012 240
2013 262
2014 332
2015 374
2016 377
2017 501
2018 500
2019 584
2020 787
2021 803
2022 1007
2023 1028
2024 1109
2025 1300
2026 678

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,010 results

Results by year

Filters applied: . Clear all
Page 1
The gut-joint axis in osteoarthritis.
Wei J, Zhang Y, Xie C, Lei G, Zeng C. Wei J, et al. Among authors: xie c. Nat Rev Rheumatol. 2026 Jun;22(6):345-361. doi: 10.1038/s41584-026-01378-2. Epub 2026 May 7. Nat Rev Rheumatol. 2026. PMID: 42098429 Review.
PRRSV-2 impedes lysosomes from eliminating secondary infected bacteria.
Zheng Z, Ling X, Qiao S, Wu J, Zhang S, Liu X, Li Y, Xie C, Ma Z, Guo X, Li Z, Feng Y, Xu L, Zhang J, Zheng H, Xiao S. Zheng Z, et al. Among authors: xie c. PLoS Pathog. 2026 Feb 27;22(2):e1014000. doi: 10.1371/journal.ppat.1014000. eCollection 2026 Feb. PLoS Pathog. 2026. PMID: 41758870 Free PMC article.
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial.
Zhong H, Wang J, Yang R, Luo Y, Zuo W, Zhang W, Xie C, Li Q, Liu Q, Xu X, Wang Q, Yu Y, Chen Y, Yi T, Min X, Shi J, Yang J, Sun H, Chen H, Shi H, Gao J, Shi J, Zhang B, Chu T, Li K, Han B; CAMPASS Investigators. Zhong H, et al. Among authors: xie c. Lancet Oncol. 2026 Apr;27(4):419-431. doi: 10.1016/S1470-2045(26)00049-5. Epub 2026 Mar 10. Lancet Oncol. 2026. PMID: 41825453 Clinical Trial.
The immunodynamics of pulmonary fibrosis.
Xie C, Ma Y, Wang Y, Gul A, Tang W, Luo Q, Xu W, Wei Y, Dong J, Liu W. Xie C, et al. Cytokine Growth Factor Rev. 2026 Jun;89:27-40. doi: 10.1016/j.cytogfr.2026.04.001. Epub 2026 Apr 15. Cytokine Growth Factor Rev. 2026. PMID: 41999680 Review.
10,010 results
You have reached the last available page of results. Please see the User Guide for more information.